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Abstract
Background: The Myc oncoprotein, a transcriptional regulator involved in the etiology of many different tumor types, has
been demonstrated to play an important role in the functions of embryonic stem (ES) cells. Nonetheless, it is still unclear as
to whether Myc has unique target and functions in ES cells.
Methodology/Principal Findings: To elucidate the role of c-Myc in murine ES cells, we mapped its genomic binding sites by
chromatin-immunoprecipitation combined with DNA microarrays (ChIP-chip). In addition to previously identified targets we
identified genes involved in pluripotency, early development, and chromatin modification/structure that are bound and
regulated by c-Myc in murine ES cells. Myc also binds and regulates loci previously identified as Polycomb (PcG) targets,
including genes that contain bivalent chromatin domains. To determine whether c-Myc influences the epigenetic state of
Myc-bound genes, we assessed the patterns of trimethylation of histone H3-K4 and H3-K27 in mES cells containing normal,
increased, and reduced levels of c-Myc. Our analysis reveals widespread and surprisingly diverse changes in repressive and
activating histone methylation marks both proximal and distal to Myc binding sites. Furthermore, analysis of bulk chromatin
from phenotypically normal c-myc null E7 embryos demonstrates a 70–80% decrease in H3-K4me3, with little change in H3-
K27me3, compared to wild-type embryos indicating that Myc is required to maintain normal levels of histone methylation.
Conclusions/Significance: We show that Myc induces widespread and diverse changes in histone methylation in ES cells.
We postulate that these changes are indirect effects of Myc mediated by its regulation of target genes involved in
chromatin remodeling. We further show that a subset of PcG-bound genes with bivalent histone methylation patterns are
bound and regulated in response to altered c-Myc levels. Our data indicate that in mES cells c-Myc binds, regulates, and
influences the histone modification patterns of genes involved in chromatin remodeling, pluripotency, and differentiation.
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Introduction
ES cells must be capable of self-renewal while simultaneously
retaining the capacity to commit to a wide range of differentiation
lineages. The notion that the determination and maintenance of
embryonic stem (ES) cell pluripotency and self-renewal is related
to an epigenetic state characterized by an open chromatin
conformation has received considerable support over the last
several years [1–6]. Open chromatin is thought to contribute to
pluripotency by permitting relatively broad accessibility to
transcriptional regulation and is itself likely to be the result of
diverse activities including nucleosome assembly, positioning, and
remodeling, incorporation of histone variants, binding of chroma-
tin modifying factors, epigenetic modifications, sub-nuclear
compartmentalization, and other dynamic processes that maintain
active chromatin (for reviews see [2,7,8]).
Much recent work on ES cell pluripotency has focused on two
aspects of transcriptional regulation: the actions of the Sox2-Oct4-
Nanog transcription factor network and the nature of epigenetic
changes associated with pluripotency [9]. The Sox2-Oct4-Nanog
transcription factors have been known for about a decade to be
required for early embryonic development and for ES cell self-
renewal [10–13]. Genome-wide binding analyses have indicated
that in both human and murine ES cells the Sox2, Oct4, and
Nanog factors occupy hundreds of gene promoters [14,15].
Importantly, these gene targets include many developmental
regulators, a subset of which, encoding transcription factors and
chromatin modifying activities, are associated with RNA poly-
merase II and are expressed in ES cells. A second subset of Sox2-
Oct4-Nanog bound genes are involved in lineage-specific
differentiation – these genes are associated with Polycomb
complex components (including Suz12, Eed, EZH2) and are
repressed in ES cells [16–18]. Therefore the Sox2-Oct4-Nanog
factors are arguably functioning as selectors of genes whose
activation or repression in ES cells are critical for pluripotency and
self-renewal.
It is likely that one reflection of the open chromatin
conformation proposed for ES cells is the relative paucity of
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comparison to non-pluripotent cells, decreased DNA methylation
and histone H3 lysine 27 trimethylation (H3-K27me3) as well as
augmentation of positive marks such as histone H4 acetylation and
H3-K4me3 [19,20] (for review see [3]). Nonetheless, the
association of Polycomb complexes with a subset of Sox2-Oct4-
Nanog bound genes that are important for cell fate transitions
[16–18] would suggest that a highly regulated form of repression
must be important in self-renewing ES cells. Indeed several studies
have confirmed the presence of H3-K27me3 at the promoters of
Polycomb bound loci, many of which overlap with Sox2-Oct4-
Nanog binding sites. Interestingly, a subgroup of these promoters
contain islands of H3-K4me3 within a larger domain of H3-
K27me3, constituting what has been termed a ’’bivalent‘‘
chromatin structure [20]. A number of these bivalent genes lose
Polycomb binding and H3-K27 methylation upon differentiation,
leading to the proposal that bivalency marks genes that are poised
for activation upon ES cell differentiation [16,20–23]. Such
bivalent domains are not restricted to ES cells and their formation
and resolution is likely to be a widespread and dynamic process
[21–23]. While loss of function of Polycomb subunits and
abolishment of H3-K27me3 results in upregulation of differenti-
ation-related bivalent genes in ES cells, these cells continue to self-
renew, indicating that Polycomb-mediated repression of these
genes is not the sole determinant of the transcriptional regulation
that maintains the undifferentiated state [24,25]. These experi-
ments prompt questions concerning the extent to which histone
modifications represent a cause or a consequence of pluripotency.
A related issue concerns the precise mechanisms through which
widespread epigenetic changes occur. Recently the histone H3-K9
demethylases Jmjd1a and Jmjd2c have been shown to be targets of
Oct4 and are implicated in the activities of the Sox2-Oct4-Nanog
network and the maintenance of pluripotency-related gene
expression [26]. However it is still unclear how these and other
histone modifying complexes are recruited to specific gene targets
in ES cells.
Another transcriptional regulatory protein that has been
connected with ES cell function is Myc. The myc oncogene family
encodes the c-, N- and L-Myc, bHLHZ proteins that hetero-
dimerize with Max and bind DNA at E-box sequences. Myc
family proteins have been associated with cell growth and
proliferation through widespread binding to DNA (on the order
of 10–20% of genomic loci are bound) and modulation of the
expression of hundreds to thousands of genes [27–31]. These
include genes encoding ribosomal RNA and ribosomal proteins as
well as many factors involved in translation and metabolism
[32–36]. myc gene expression is itself regulated by many different
mitogens, cytokines, and growth factors, suggesting that Myc
serves as an integrator of signal transduction. As such, Myc
proteins are likely to link extracellular signals to an acute cellular
growth response [37–39]. It is therefore unsurprising that Myc is
expressed in different types of stem cells including ES cells
[40–43]. Yet there are several lines of evidence indicating that
Myc may function as a regulator of pluripotency. For example,
although Myc expression has long been associated with the
inhibition of terminal differentiation, recent studies have indicated
that it can also drive diverse progenitor cell types down
differentiation pathways [44–46]. Moreover, c-myc loss of function
in hematopoietic stem cells leads to their retention in the stem cell
niche and inhibition of differentiation [47] while deletion of both
N- and c-myc results in their ablation [48] . Importantly, in ES cells
c-Myc appears to be critical in maintaining self-renewal and
inhibiting differentiation [41,49]. Moreover, myc family genes have
been shown to cooperate with Sox2, Oct3/4 and Klf4 in the
conversion of murine embryo fibroblasts (MEFs) into induced
pluripotent stem cells (iPS) [50–52] (for review see [9]). In the
generation of iPS cells myc can be replaced by other factors but at
the cost of greatly diminished efficiency [53,54]. Fibroblasts
reprogrammed by Myc, Oct4, Sox2 and Klf4 display widespread
epigenetic changes characteristic of the chromatin in ES cells [55].
In this regard it is interesting that myc loss of function has been
associated with a reversible global change in histone acetylation
and methylation [56]. Furthermore induction of c-Myc in a B cell
line results in increased histone H3 and H4 acetylation at a defined
group of Myc target genes [57]. Reasoning that Myc may have
gene targets and functions that are unique to ES cells we have
carried out a genome location (ChIP-chip) analysis of c-Myc
binding in mES cells and examined the consequences of altering
Myc levels on histone methylation. Our data indicate that Myc is
involved in the transcriptional regulation of several members of
the ES cell pluripotency network and in widespread histone
methylation mediated by the Polycomb complex.
Results
Identification of Genes Bound and Regulated by c-Myc in
ES Cells
We mapped genomic binding sites for endogenous c-Myc in
murine embryonic stem (ES) cells by employing DNA derived
from anti-Myc chromatin-immunoprecipitation to probe DNA
microarrays (ChIP-chip) comprised of 21,632 mouse gene
promoters. For these experiments we employed sorted SSEA-1
positive R1 and AK7 ES cells and a pre-absorbed antibody with
reactivity restricted to c-Myc protein (see Materials and Methods).
We imposed a cut-off of four-fold enrichment following chromatin
immunoprecipitation with anti-Myc compared to input, and also
applied the widely used ACME/R analysis software to identify
significant peaks across gene promoters by assigning a probability
value (p-value) to each probe in the array (we used p-
value,0.0001 as our cut-off) [58,59] (see Materials and Methods
and Figure. S1, Table S1). Using these approaches we identified
3189 promoter binding sites representing 12.8% of promoters
analyzed. Examples of enrichment profiles (ChIP-enriched versus
total genomic DNA) observed for Myc binding within a ,5k b
region of the transcriptional start sites of the genes encoding the
histone chaperone HirA, the histone demethylase SMCX, and the
Sox2 transcription factor are shown in Figure 1A (see Table S1 for
list of c-Myc-bound genes). The percentage of c-Myc bound
promoters identified is comparable with earlier promoter and
genomic binding experiments in Drosophila and mammalian cells
[27–29,31]. We further validated association of c-Myc with a
subset of the genomic loci identified in our ChIP-chip experiments
by employing qChIP-PCR in four independent experiments with
c-Myc antibody, carried out using two different ES cells lines (AK7
and R1) (Figure 1B, Figure S2). We randomly selected 44 genes for
validation. Nineteen of these genes (Dlx-1, Evx2, Nkx2.2, Nkx2.9,
Gata1, Pax5, Sox21, Sox7, Pax9, Pax6, Onecut1, Hes1, Oct3/4,
Gata4, Cdx2, Mash1, Irx5, Math1, Cdk4) were not bound by Myc
in the ChIP-chip assay and did not meet our criteria (.2 fold
enrichment) for Myc binding in the qChIP-PCR. Two genes (Irx2
and Msx1) were negative in our ChIP-chip assay but positive in
qChIP-PCR, and one gene (NeuroD2) was positive in the ChIP-
chip assay but fell below the cut-off in the qChIP-PCR. The
remaining genes were positive in both assays (Figure 1B). From
these data we calculate an average false discovery rate of 6.8%
AK7 ES cells and 11.3% in R1 ES cells.
To determine whether c-Myc regulates the levels of expression
of genes identified in our analysis we examined the transcript levels
Myc Function in ES Cells
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in our ChIP-chip experiments (Figure 2A, B). We manipulated c-
Myc abundance in ES cells by employing Lentiviral vectors to
drive overexpression of c-myc, or to introduce shRNAs designed to
knockdown c-myc expression. We observed an 8-fold average
increase in c-myc RNA levels following infection with c-myc
expressing Lentiviruses and a 4-fold decrease in c-myc RNA after
introduction of shRNA directed against c-myc (Figure 2A, B, far
left). Myc protein levels were also shown to respond to
introduction of the c-myc shRNA and overexpression vectors
[60]. These changes in c-Myc protein level induced altered
proliferation rates where increased c-Myc resulted in increased
BrdU incorporation and decreased population doubling time,
while c-Myc knockdown has the opposite effect (Figure S3). Nearly
90% (30/33) of the c-Myc target genes examined showed a two-
fold or greater augmentation of expression following c-myc
overexpression (Figure 2A). Twenty-four genes in this group
displayed decreased levels of expression subsequent to c-myc
knockdown (Figure 2B). Of the 33 genes examined, three genes
(Gata6, Pcdh-a . Pcdh-c) appeared to be either marginally or
substantially downregulated upon c-myc overexpression
(Figure 2A). GATA 6 also displayed increased expression upon
c-myc knockdown, indicating that it is repressed by c-Myc. This is
consistent with considerable data showing that myc has a
repressive, as well as an activating, role in transcription (for
review see [61]).
c-Myc Associates with ES Cell Genes Involved in
Chromatin Structure and Pluripotency
Ontology analysis of genes associated with endogenous c-Myc in
ES cells indicates, as expected from previous studies, that they fall
into multiple functional classes involving growth, metabolism, cell
signaling pathways, cell cycle progression, and apoptosis.
In mES cells we also detect c-Myc binding to genes involved in
developmental processes (e.g. neurogenesis and ectoderm devel-
opment) (see Figure 3A) as well as genes involved in chromatin
structure, such as the histone chaperone HirA, the histone lysine
demethylase SMCX, and the SWI/SNF related SMARC genes
(see Figure 1, Table S1). Such genes have not been previously
linked to c-Myc binding or regulation and likely represent mES
cell-specific c-Myc targets. Of particular interest is our finding that
the sox2 gene is bound by c-Myc proximal to the transcription start
site (TSS) in ES cells (Figure 1A), an interaction confirmed by
Figure 1. c-Myc-bound promoters in mouse embryonic stem cells identified by ChIP-chip analysis and validated by qChIP-PCR. (A)
Examples of three gene promoter regions identified using chromatin immunoprecipitation with anti-c-Myc antibody to probe DNA microarrays (see
Methods and Materials for details). Shown are the fold enrichment ratios for anti-Myc ChIP-enriched versus total input genomic DNA (y axis) for all
probes within the genomic regions indicated. Numbers represent the beginning and the end probe positions (x axis). The transcriptional start sites
and direction of transcription are noted by arrows. (B) Validation by qChIP-PCR of putative c-Myc target genes in AK7 mES cells. Forty-four genes were
selected at random for validation and included c-Myc target and non-c-Myc target genes as determined from the initial promoter array. Equal
amounts of anti-c-Myc ChIP DNA and total input DNA were used for quantitative PCR employing SYBR Green detection with an ABI7900HT system.
Bar heights represent the average fold enrichment ratios from 2 independent sets of anti-Myc ChIP-enriched versus total input genomic DNA. qChIP-
PCR data derived for R1 mES cells is shown in Supplementary Figure S2).
doi:10.1371/journal.pone.0007839.g001
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increases ,8-fold in response to c-myc overexpression and
decreases 2-fold when endogenous c-myc expression is reduced
by shRNA (Figure 2A, B). As expected, we also observe changes in
Sox2 protein level following modulation of c-Myc expression
(Figure 2C, Figure S4). Because Sox2 and its binding partner
Oct3/4 are key components of a transcription factor network that
can induce pluripotency in human and murine fibroblasts [51–53]
it is possible that Myc participates in this network, at least in part,
through its ability to stimulate Sox2 expression.
c-Myc Associates with a Subset of Polycomb-Regulated
and Bivalent Genes in ES Cells
In Drosophila,d myc and polycomb (PcG) interact genetically [62]
and genes in the trithorax group, that oppose PcG function, have
been demonstrated to interact with dmyc genetically and
physically [63,64]. To test the hypothesis that c-Myc impinges
on PcG function in mES cells, we compared c-Myc and PcG
binding more extensively. In ES cells, PcG complex binding has
been previously identified through genome-wide location analysis
and found to associate with, and transcriptionally repress
developmental regulatory genes [16,18]. We compared our mES
c-Myc binding data and the mES PcG ChIP-chip data from the
study of Boyer et al, [16] (Table S2) and found that of our 2282 c-
Myc-bound promoters represented on the Boyer et al. array 9.5%
are H3-K27 methylated and associated with the PcG protein
Suz12 (p=3.4E203, Chi-square calculation). This represents 18%
of Suz12 + H3-K27me3 genes and 17% of all genes displaying
H3K27 trimethylation (p=2.9E203) (Figure 3B, Table S2). The
overlapping Suz12/H3-K27me3/c-Myc genes predominantly
Figure 2. Transcriptional response of c-Myc target genes to c-Myc overexpression or knockdown. (A) Response of a subset of c-Myc
target genes to Lentiviral mediated overexpression c-Myc in mES cells as determined by Real-Time PCR. Each bar represents the average (DDCt) from
triplicate sets of experiments on a log2 scale after normalization to internal controls and vector alone. The fold differences detected range from ,2–
20 fold. Note an approximately eight-fold increase in c-myc RNA levels (bar at far left). Color-coded genes are read from left to right (inset). (B)
Response of a subset of c-Myc target genes to RNAi mediated knock-down of c-Myc in mES cells as determined by Real-Time PCR. Each bar represents
the average (DDCt) from a triplicate set of experiments on a log2 scale after normalization to internal controls and vector alone. c-myc RNA levels
decreased 4 fold (bar at far left). Color-coded genes are read from left to right (inset). * indicates previously identified bivalent gene. (C) Sox2
immunostaining in mES cells. mES cells were infected with empty lentiviral vector alone (WT; left panel); lentiviral vector expressing shRNA againstc -
myc (middle panel); lentiviral vector expressing c-myc (right panel). Scale bar indicates 50 mm See Supplementary Figure S4 for immunoblots of Sox2
protein.
doi:10.1371/journal.pone.0007839.g002
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differentiation (Figure 3C) such as Ebf2, MyoD1, Hand1, Isl1
and Atoh1, the homeobox gene family members Hox b,c,d, and
genes involved in critical signaling pathways such as Wnt and FGF
(for gene list see Table S2).
Our ChIP-chip analysis also revealed that among the group of
PcG bound genes associated with c-Myc are many genes
previously characterized as possessing bivalent chromatin marks
[20,21]. Furthermore when we examined a group of these known
bivalent genes by qPCR we found that they are induced by c-myc
overexpression and repressed following c-myc knockdown (e.g.
Zic4, Ebf1 and Foxp2, Fgf5, Fgf18, Ebf2, Hand1, Olig2, Lhx2,
HoxB3, Olig 3, Tcfap2b, En2, Atoh1, Ngn2, Ngn3, Gata6 marked
by asterisks in Figure 2). These findings indicate that c-Myc binds
to and can regulate PcG silenced genes in ES cells.
c-Myc Influences the Level and Pattern of Histone H3
Lysine Methylation in ES Cells
Myc has been linked to histone methylation through its
inhibitory interaction with the LID histone H3-K4me3 demethy-
lase in Drosophila [63] and by Myc’s apparent preference for
binding to promoters that are methylated at H3-K4 [57,65].
Above we have described Myc binding to PcG target genes that
contain an H3-K27me3 mark (see Figure 3B). To determine if
changes in c-Myc abundance affects the levels of H3-K4me3 and
H3-K27me3, we carried out lentiviral-mediated Myc expression
and determined the presence of these two histone marks in bulk
chromatin using Western blotting. Introduction of the c-myc
shRNA and overexpression vectors results in the expected changes
in Myc protein levels (Figure 4A). Our results show that an
approximately 8-fold increase c-Myc augments H3K4me3 abun-
dance by 50–60% (Figure 4A). By contrast, H3K4me3 levels are
decreased ,30% subsequent to c-Myc knock-down (Figure 4A).
When we examined H3-K27me3 under the same conditions we
were unable to detect any significant change.
To determine whether loss of c-Myc expression has a significant
effect on H3K4me3 level during embryonic development we
examined embryos from wildtype and c-myc null mice. Targeted
deletion of both c-myc alleles results in embryonic lethality at E10.5
[66] due to defective hematopoiesis [67]. When we analyzed c-myc
null embryos at E7, a time when no phenotypic change is apparent
between wildtype and c-myc null embryos, we found a dramatic
(,70–80%) decrease in H3K4me3 levels, but no significant
change in H3K27me3 compared to wildtype. Our results suggests
that c-Myc expression is involved in maintaining H3K4me3 levels
in ES cells and in early embryonic development (Figure 4C).
To examine whether changes in Myc levels influence the H3
methylation landscape at individual Myc-bound genes in ES cells
we extended our ChIP-chip analysis using antibodies against H3-
K27me3 and H3-K4me3. We employed a custom-designed
oligonucleotide tiling array of 815 promoter regions including
promoters of genes that were bound by both Myc and Polycomb
Figure 3. c-Myc, and Polycomb proteins share target genes. (A) Gene Ontology categories of c-Myc associated genes in murine ES cells.
Functional categories derived for genes enriched at least 4-fold for c-Myc binding and possessing an ACME p,0.0001 in the ChIP-chip assay (see
Materials and Methods and Supplementary Table S1). The numbers to the right represent the p-values for the statistical over-representation in each
category. (B) Venn diagram depicting the overlap among murine ES cell genes bound by c-Myc (this paper), Suz12, and those displaying
trimethylation of H3-K27 [16]. Nearly 96% of promoters bound by Suz12 also show the H3-K27me3 mark. Of genes associated with Myc (2282) 17%
are associated with the H3-K27me3 mark and 9.5% associated with both Suz12 and H3-K27me3 (for gene list see Supplementary Table S3). (C) Gene
ontology categories of gene displaying overlap among c-Myc, Suz12 binding and H3-K27me3 marks. Functional categories were derived for genes
enriched at least 4-fold for c-Myc binding in the ChIP-chip assay (see Methods and Supplementary Table S1). Suz12 and H3-K27me3 bound genes
were previously described [16]. Numbers to the right are p-values for the statistical over-representation among genes within a functional category.
doi:10.1371/journal.pone.0007839.g003
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Polycomb but not Myc, selecting genes that are predominantly
linked to PcG binding, differentiation, pluripotency, and chroma-
tin modification (Table S4). We first carried out anti-Myc
chromatin immunoprecipitation on this custom array permitting
us to verify our initial array data and examine the effects of
modulating Myc levels. We compared vector-alone treated mES
with mES cells overexpressing c-myc (mES qc-myc) and mES cells
in which c-myc has been knocked down (mES Q c-myc). Figure 5
shows c-Myc binding to a representative group of promoters. We
plotted log2 enrichment profiles to permit us to more easily
compare wildtype ES cells with the mES Q c-myc and mES qc-
myc cells. Here negative enrichment ratios indicate that the signal
from the anti-Myc ChIP was less than the input DNA against
which it was normalized. Ebf1, Ebf2, Olig3, Gata6, and Sox 2
display significant endogenous c-Myc binding at several sites
within their promoters in mES cells (Figure 5 blue bars, Figure
S10) consistent with our promoter array data (Table S1). Hes1,
Onecut1, and Jak2 were not identified as positive for Myc binding
on the original promoter array, and show relatively low levels of
endogenous c-Myc binding in this high density tiling array (Figure
S10). Overexpression of c-Myc generally results in increased
enrichment (red bars) at endogenous binding sites, although in
some promoters we observe overexpressed c-Myc binding at a
small number of sites where no or very low endogenous binding
signal is detected (e.g. Ebf2, Hes1, Olig3, Gata6) consistent with
previously observed occupation of low affinity binding sites at
higher Myc levels [27]. By contrast, shRNA-mediated knockdown
of c-Myc invariably leads to reduced Myc binding (green bars).
These findings further validate our Myc binding assignments and
indicate that the extent of binding is dependent on c-Myc levels.
When we plotted histone H3 methylation profiles we found that
nearly all promoters on our custom array (,95%) displayed
changes in the intensity and position of H3-K27me3 and/or H3-
K4me3 peaks in response to altered Myc levels (profiles for 427
promoters are provided in Figures S5, S6, S7, S8, and S9).
However the extent and type of change appear to be largely
promoter-specific. Fig. 6 shows H3-K27me3 (red) and H3-K4me3
(green) in wildtype mES, mESqc-myc, and mESQc-myc cells over
a 3KB to 5KB region proximal to the TSS of a subset of genes that
are illustrative of the types of changes observed more generally (see
Figures S5, S6, S7, S8, and S9). Sox2 is a c-Myc bound and
regulated gene (Figure 1, 2, 6) that is not known to be a PcG target
and, as expected, we fail to observe peaks of H3-K27me3 in the
Figure 4. Quantitation of H3K4me3 and H3K27me3 levels in response to c-Myc. (A) Response of H3K4me3 to Lentiviral mediated
overexpression or knock-down c-Myc in mES cells as determined by western blot. (B) Response of H3K27me3 to Lentiviral mediated overexpression
or knock-down c-Myc in mES cells as determined by western blot. (C) Effect of H3K4me3 and H3K27me3 level in response to c-Myc loss in early
developmental embryos. Ratios based on normalization to c-tubulin internal control wwere calculated using ImageJ software .
doi:10.1371/journal.pone.0007839.g004
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However, H3-K4me3 is apparent in the sox 2 promoter region in
mES and shows, in mESqc-myc cells, an increased signal near the
sox 2 TSS compared to wildtype mES cells (Figure 6A). The
presence of an augmented H3-K4me3 peak is consistent with our
finding that Sox2 is induced by c-myc overexpression (Figure 2A)
(see Discussion). In contrast, c-myc knockdown abolishes H3-
K4me3 and leads to repression of sox2 (Figure 2B). Interestingly, a
small peak of H3-K27me3 is present at the sox2 promoter in
mESQc-myc cells, suggesting that loss of c-Myc binding may lead
to PcG activity, at least within this promoter region (Figure 6A).
In ,13% of the Myc targeted promoters on our custom array
the overexpression of c-myc increased the levels of H3K4me3 and
decreased H3K27me3 levels. Genes with enriched H3K4me3 in
mESqc-myc cells, such as Ebf1, Ebf2, and Sox2 (Figure 6A)
encode transcription factors involved in early development. Their
expression levels increase in mESqc-myc and decrease in
mESQc-myc cells relative to wildtype mES cells (Figure 2). In
addition, Ebf1, Ebf2 and Olig 3 were previously identified as
bivalent genes [20] and indeed we observe that their H3-K4me3
and H3-K27me3 peaks overlap in wildtype mES cells (Figure 6
blue asterisks). For these promoters, augmentation of c-Myc levels
results in an apparent resolution of the bivalency. Knockdown of
c-Myc had little effect on H3-K4me3 distribution compared to
wildtype mES cells although H3-K27me3 peaks are enhanced and
clearly display changes in position. Loss of bivalency with c-myc
overexpression was observed in ,32% of genes on the custom
array (Table S3).
A different pattern emerged from our analysis of another subset
of promoters. Here, overexpression of c-Myc frequently results in
enrichment of promoter proximal H3-K27me3. These include
genes involved in differentiation such as MyoD1, mesenchyme
homeobox 2 (Meox2), and Smarca2 (also known as Brahma, a
component of the SWI/SNF related chromatin remodeling
complex) or genes highly expressed in differentiated cells such as
very low density lipoprotein receptor (VLDLR), glutamate
receptor (Grm7), dopamine receptor D4 (Drd4), and the
protocadherin cluster (see Table S3). Within the GATA6
promoter, Myc overexpression induced an H3-K4me3 peak as
well as an overlapping H3-K27me3 peak, thereby creating a new
bivalent region (Figure 6). GATA6 expression is repressed under
these conditions (Figure 2A,B). Knockdown of c-Myc results in
decreased H3-K4me3 in the presence of widespread H3-K27me3.
Therefore induction of GATA6 expression upon c-Myc knock-
down (Figure 2A,B) is presumably dependent on other changes in
chromatin modification or remodeling independent of H3
methylation (Figure 2).
Analysis of a group of genes that did not score as Myc targets
showed no or only small changes in methylation patterns
(Figure 6B). However we find that some non-Myc targets such
as Jak2, Hes1, and Onecut1 reveal changes in H3 methylation
(Figure 6B). Jak2 shows an increase and spreading of H3-K27me3
as well as H3-K4me3 over the promoter region. mESQc-myc cells
display a nearly complete loss of the H3-K27me3 and a
diminished intensity of H3-K4me3 in the Jak2 promoter region.
Onecut1 and Hes1 also display changes in both H3-K27me3 and/
or H3-K4me3 in response to changes in Myc levels. These effects
are likely due to secondary or long-range effects of Myc on
chromatin (see Discussion). Overall our data suggest that altering
Myc levels induces varied and widespread changes in methylation
patterns.
Discussion
The recent findingsthat Myc family proteins cancollaboratewith
other transcription factors (Oct4, Sox2, Klf4) to reprogram mouse
and human fibroblasts [50,51,68–70] as well as earlier work
showing the importance of c-Myc in maintenance of mES cell self-
renewal [41] prompted us to examine the nature of c-Myc target
genes in mES cells using ChIP-chip analysis. Previous studies
employing ChIP-chip and Chip-PET in human cells and DamID in
Figure 5. c-Myc binding sites on a subset of gene promoters in
mES cells. c-Myc levels were manipulated by Lentiviral-delivered
overexpression or knock-down of c-Myc in mES cells followed by anti-
Myc ChIP-chip analysis on custom- designed arrays (see text).
Unprocessed enrichment ratios (log2 scale) present ChIP-enriched
versus total input genomic DNA (crosslinked, sonicated and processed
identically to the ChIP sample) (y axis) for all probes within a genomic
region 2 kb upstream and 1 kb downstream of the TSS. The TSS and
direction of transcription are denoted by arrows at the bottom of the
figure. Blue bars: endogenous c-Myc binding in WT mES cells, Red bars:
Myc overexpressing mES cells, Green bars: Myc knock-down mES cells.
Negative values occur when there is no enrichment in ChIP DNA relative
to input.
doi:10.1371/journal.pone.0007839.g005
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Genomic loci associated with Myc binding were found to
encompass a wide range of biological functions including metab-
olism, protein biosynthesis, and cell signaling – functions generally
consistent with the ability of Myc proteins to stimulate cell growth.
Our ChIP-chip analysis of Myc bound loci in mES cells has
identified a similarly broad range of functional categories related to
growth and metabolism among 3189 binding sites. However,
among the mES cell c-Myc targets identified here, we also detected
genes involved in developmental processes (e.g. Sox2, Ebf1, Atoh1,
En1, Hand1, Bmi1, Suz12) many of which had not been previously
connected to Myc. We also detected genes not previously identified
as Myc targets that are involved in chromatin assembly and
modification including HirA, HirIP5, SMCX, SMRCA2, Anp32b,
and Anp32e. Examination of gene targets using qChIP-PCR and/
or RT-PCR confirmed that many are bound and regulated by Myc.
That Myc can elicit cell-type specific gene regulatory programs had
beenearliersuggested byaseriesofexpressionprofilingexperiments
in pancreatic b-cells that uncovered a striking, and most likely
direct, regulation of pancreatic cell-specific differentiation related
genes by c-Myc [71]. Our data indicate that in mES cells Myc
participates in binding and regulation of genes important in
controlling aspects of chromatin structure and pluripotency. That
Myc affects ES cell biology is consistent with an earlier study
employing overexpression of mutant forms of Myc and demon-
strated that c-Myc promoted mES cell self-renewal through
inhibition of differentiation [41] as well as recent data demonstrat-
ing that Myc regulates ES cell differentiation through the induction
of a specific subset of microRNAs [60].
While this work was in progress three reports were published
describing Myc binding sites in ES cells [72–74]. Two of these
studies focused on binding by multiple core transcription factors
[72,73] and the third examined Stat3 and Myc [74]. In these
reports Myc binding was largely examined in the context of
binding and gene regulation by these other factors. In this paper
we have used cells sorted for the ES cell marker SSEA-1 to achieve
a highly purified and phenotypically uniform population of ES
cells. In addition we not only identified genes bound by
endogenous c-Myc in ES cells but have examined the effects of
Myc overexpression and knockdown on promoter occupancy and
the landscape of H3-K4 and H3-K27 methylation. In general
while our results agree with these reports in finding widespread
binding of Myc to many genes critically involved in ES cell
function, we have also found evidence implicating Myc in histone
methylation and in bivalency in a subset of PcG target genes.
Participation of Myc in ES Cell Transcription Circuitry
It is noteworthy that sox2, encoding a critical transcription factor
regulating pluripotency, is regulated and bound by Myc.
Moreover histone H3 methylation at the sox2 promoter is altered
in response to changes in c-myc abundance. This result is consistent
with a previous study demonstrating elevated Sox2, among other
pluripotency factors, in an ES cell-like expression module
discovered in diverse human epithelial cancers [76]. Recently
several pluripotency genes have been shown to be regulated by N-
Myc overexpression in neuroblastoma [75]. This raises the
possibility that Myc may participate in the Sox2 pluripotency
network by directly up regulating Sox 2. We also detected overlap
between Myc targets and genes marked by H3-K27me3 and
Suz12 binding. Other studies have reported only a low correlation
between c-Myc targets and H3-K27me3 [65,73]. Our data are
consistent with this work in that we find only a fraction of Myc
Figure 6. c-Myc levels influence the pattern of histone H3 lysine methylation in mES cells. (A) a group of genes bound by c-Myc (B) a
group of non-Myc target genes. c-Myc levels were manipulated by (1) Lentiviral-delivered overexpression (qc-Myc) (2) knock-down (Q c-Myc), or (3)
empty lentiviral vector control in ES cells. ChIP DNA isolated with anti-H3K4me3 or anti-H3-K27me3 was applied to the custom-designed arrays (see
text). Enrichment ratios (log2 scale) for ChIP-enriched versus total input genomic DNA were processed by ACME and the given p values (2log10; y
axis) identifying significant sites were plotted (see Methods). Red peaks present H3-K27me3 and green peaks present H3K4me3. Tick marks on the y-
axis are spaced 400 bp apart. Asterisks mark positions of overlapping (bivalent) H3-K4me3 and H3-K27me3 peaks. The arrows at bottom indicate
transcriptional start sites.
doi:10.1371/journal.pone.0007839.g006
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does not associate with H3-K27 methylated gene regions.
However the 218 genes that do display Myc, Suz12 and H3-
K27me3 overlap include many transcription factors involved in
developmental regulation of differentiation functions (predomi-
nantly ectoderm and neuronal differentiation). The genes
encoding these transcription factors are repressed by PcG
complexes (including the Suz12 subunit) in ES cells [16–18].
Importantly, of the 17 common Myc-PcG target genes tested we
found that 14 (Fgf18, EBF1, EBF2, Zic4, En2, Bmi1, Lhx2, Fgf5,
Ngn2, Ngn3, Olig 2, Olig3, Atoh1, and HoxB3) are activated
upon Myc overexpression and repressed subsequent to Myc
knockdown in mES cells (Figure 2A, B). Because many of these
promoters marked by H3-K27me3 are considered bivalent
[21–23] we surmise that Myc is involved in the maintenance of
the bivalent state.
Myc Influences the H3 Lysine Methylation Landscape
While there is a compelling connection between Myc binding
and the induction of histone acetylation [57,65,77] it is less clear
how Myc influences histone methylation. In a human B cell line
Myc binding is strongly associated with promoters marked by H3-
K4me3 prior to the induction of Myc [65]. In Drosophila dMyc
binds to and inhibits the activity of the H3-K4me3 demethylase
Lid, [63] suggesting that at least in this system Myc may act to
maintain H3-K4 methylation levels by blocking the action of a
demethylase [63]. When we analyzed c-Myc regulation of H3-K4
and H3-K27 methylation in bulk chromatin derived from ES cells
we found that H3-K3me3 levels positively correlate with c-Myc
levels while H3-K27me3 levels were unaffected by c-Myc
abundance (Figure 4A, B). Surprisingly, phenotypically normal
E7 embryos from c-myc null mice (approximately 3 days prior to
the advent of embryonic lethality) have strikingly reduced H3-
K4me3, while H3-K27me3 was essentially unchanged (Figure 4C).
This result extends our earlier work demonstrating global
decreases in H3-K9 methylation and H3/H4 acetylation in bulk
chromatin in the nervous system and in cell lines upon Myc loss of
function [56].
To examine the effects of c-Myc levels on individual genes we
analyzed H3-K4 and H3-K27 trimethylation within the subset of
Myc associated genes linked to PcG binding, differentiation,
pluripotency, and chromatin modification. Our results show broad
and complex changes in the trimethylation patterns of both H3-
K27 and H3-K4 in nearly all the promoters on the array in
response to altered Myc levels. These changes display several
noteworthy features. First, H3 methylation changes in response to
altered Myc levels are generally, but not exclusively, observed in
promoter regions directly bound by Myc. However, while Myc
binding sites are frequently proximal to altered H3 methylation
sites, peaks of Myc binding can also be found several kb away.
Second, the patterns of H3 methylation changes observed appear
to be promoter specific. A recent study in human B cells also
reported that induction of Myc resulted in histone methylation
changes at individual promoters at both Myc and non-Myc target
genes [57]. Here we find that methylation changes can take the
form of shifts in position within the promoter and/or quantitative
changes that presumably reflect changes in the fraction of mES
cells containing the altered methylation mark. Third, H3-K27 and
K3-K4 methylation bivalency is both lost and gained depending
on the specific promoter and the levels of Myc. It is important to
note that while the changes observed in H3-K4 and H3-K27
trimethylation patterns can be construed as consistent with
activation or repression in response to changes in c-Myc levels,
we have also observed cases where altered methylation patterns do
not correspond to changes in gene expression. This is consistent
with a previous study demonstrating that during differentiation
active PcG recruitment to some genes can result in increased
H3K27me3 but not to inhibition of transcription [25]. H3-K4 and
H3-K27 methylation patterns represent only a part of the complex
interplay of modifications and factors involved in chromatin
structure and gene regulation [73,78] underscoring the impor-
tance of more detailed analysis of other histone marks and
transcription factor interactions at individual promoters.
Mechanisms of Epigenetic Regulation Mediated by Myc
How does Myc elicit changes in the histone H3 methylation
patterns of promoters in mES cells? A great deal of previous work
has indicated that the Myc protein recruits multiple activities
involved in chromatin modification – these include histone
acetyltransferases (GCN5, Tip60, p300), potential chromatin
remodelers (p400, Ini1, Tip48/49), ubiquitin ligases (Fbw7,
Skp2), the H3-specific kinase Pim1, the HDAC1 histone
deacetylase, and the JARID1A/LID histone H3-K4 demethylase
(for reviews see [38,61,79]). Furthermore, studies in Drosophila
indicate that dMyc interacts with members of the Trithorax group,
including components of histone methyltransferases and Swi/Snf
remodeling complexes [63,64]. It is likely that the precise mix of
co-regulators recruited by Myc to DNA is determined in a context-
specific manner and, given the short half-life of Myc proteins, is
subject to rapid exchange. The consequences of these multiple
interactions are predicted to have profound effects on chromatin
proximal to Myc binding sites and may in principle lead to erasure
or establishment of H3 methylation patterns. Such modification
patterns may be spread along chromatin, as has been suggested for
H3-K9 and H3-K27 methylation and heterochromatin formation
[80]. These effects may be reinforced by the nature of the target
genes induced by Myc which include chromatin modification
enzymes (GCN5, SMCX) and remodelers (SMARC). Moreover,
recent work has shown that nucleosome replacement mediated by
factors controlling assembly and disassembly may underlie
epigenetic changes that govern accessibility of transcription factor
to promoters (for review see [8]). In this regard it is of interest that
the gene encoding the histone assembly factor HirA is bound and
regulated by Myc. HirA levels have been previously shown to
regulate unbound histones and ES cell differentiation [1].
Therefore Myc may stimulate a more generalized nucleosome
instability leading to widespread changes in epigenetic marks.
Such generalized effects of Myc -through spreading of chromatin
modifications, through induction of Myc target genes which
themselves modify chromatin, and through nucleosome instability
– may account for the fact that we detect changes in histone
methylation patterns in regions distant from Myc binding sites and
in promoters in which Myc is not bound. We surmise that the
ability of Myc to broadly affect the epigenetic marks and
expression of genes important in pluripotency and differentiation
is related for Myc’s role as a reprogramming factor critical in the
generation of iPS cells.
Materials and Methods
Cell Culture
The ES cell lines, R1 and AK7, the most commonly used cell
lines for generating transgenic mice, were obtained from Andras
Nagy and Philippe Soriano respectively. Both mES cell lines were
cultured in DMEM supplied with 10% FBS, L-glutamine, non-
essential amino acid, sodium pyruvate, LIF (leukemia inhibitory
factor), and b-mercaptoethanol. ES cells were thawed on plates
with a mitomycin C-treated mouse embryonic fibroblast feeder
Myc Function in ES Cells
PLoS ONE | www.plosone.org 9 November 2009 | Volume 4 | Issue 11 | e7839layer and then grown and expanded on 0.1% gelatin-coated plates
(without feeder cells) in medium containing LIF for subsequent
experiments.
c-Myc Constitutive Knock-Out Mice
The c-Myc constitutive knock-out mice were generated by
crossing more-Cre and c-Myc
floxed/floxed mice (a gift of I.M. de
Albora ´n) to delete the floxed c-Myc allele and then back-crossing
to wild-type to remove more-Cre. The resulting c-Myc heterozy-
gous mice were bred to obtain the c-Myc null embryos for further
experiments.
Ethics Statement
All research involving mice has been conducted according to
the Institutional Animal Care and Use Committee Guidelines and
has been pre-approved by the Institutional Review Board at the
Fred Hutchinson Cancer Research Center.
Chromatin Immunoprecipitation (ChIP) and DNA
Microarrays (ChIP-chip)
ES cells were purified by SSEA-1 flow sorting and treated with
1.1% formaldehyde for crosslinking which was terminated with
0.125M glycine before lysis and sonication to produce 0.2,1kb
DNA fragments. Protein-A- agarose and protein-G-sepharose
beads were blocked with 1 mg/ml sonicated salmon sperm DNA
and 0.5 mg/ml BSA and washed twice in lysis/sonication buffer
(50 mM Tris, 10 mM EDTA, 1%SDS, pH=8). For ChIP with
mouse monoclonal or rabbit polyclonal antibody, chromatin was
pre-cleared with appropriate beads before immunoprecipitation
overnight with antibody. Antibodies used for chromatin immuno-
precipitation were c-Myc (Santa Cruz Biotechnology Inc.
#SC764, Lot:F1307; Ab5 mouse monoclonal antibody from
Thermo Scientific #MS-1054), H3K4me3 (Upstate, #05-745),
and H3K27me3 (Upstate, #07-449), EZH2 (Abcam, #Ab3748-
100), and Suz12 (Upstate #07-379). The N262 antibody antibody
has been used extensively for ChIP of c-Myc [27,31,81]. We
further pre-absorbed the N262 antibody with electrophoretically
fractionated proteins extracted from c-Myc null embryos and
demonstrated that the pre-absorbed antibody is specific for c-Myc
protein and does not cross-react with N-Myc as determined by IP-
western blotting.
Chromatin immunoprecipitation and amplification (ligation-
mediated PCR) for ChIP-chip analysis were carried out according
to the Roche/NimbleGen protocol. Input DNA represents an
aliquot of chromatin from the same sample used for ChIP and was
crosslinked, sonicated, and processed identically to the ChIP
sample. Duplicate samples were applied to the arrays. Our initial
mouse promoter DNA microarray comprised 21,632 putative
promoters from annotated mouse genes (NimbleGen, two mm8
promoter arrays). Using R software (http://www.R-project.org),
we merged normalized data with the corresponding gene
identifiers. Genes bound by Myc were identified as those in which
any probe in the 5 kb promoter segment had a log2-ratio (ChIP vs.
input DNA) .2. Data was further analyzed by the ACME
package (www.bioconductor.org), a computer program developed
for analysis of data obtained from NimbleGen-tiled microarrays,
using a window of 500 bases and a threshold =0.95 [58] [R
Development Core Team (2008). R: A language and environment
for statistical computing. R Foundation for Statistical Computing,
Vienna, Austria. ISBN 3-900051-07-0].
To validate the ChIP-chip data from the promoter array, 1 ng
input and ChIP DNA for Real-Time PCR was carried out using
SYBR green PCR mix (Applied Biosystems) on ABI7900HT
detection system. The Ab5, c-Myc specific antibody was used for
qChIP-PCR validation. The enrichment ratio was calculated by
ChIP versus input and the positive targets were determined by
criteria of 2-fold enrichment. We evaluated enrichment from
duplicates of 2 independent ChIP assays obtained from both the
R1 and AK7 ES cell lines. The sequences for all primers for ChIP-
PCR are available upon request.
Custom-design DNA microarrays for a subset of genes (see text)
were tiled through .5 kb upstream and 1 kb downstream of
transcription start sites using isothermal probes of 70–80
nucleotides. Triplicate samples were applied to the array.
Genomic sites enriched for H3-K4me3 or H3-K27me3 binding
were identified using ACME (window=200, thresh=0.9) and the
given p values for each probes from ACME were plotted into
graphs using the SAS 9.1 program.
Analysis of Myc Target Genes
To determine overlap among genes bound by c-Myc in mES
cells (this paper) as well as by PcG and H3-K27me3 in mES cells
we merged the list of genes on our arrays with those on the
platform used by Boyer, et. al. [16].The majority of PcG bound
sequences were detected within 1 kb of transcription start site [16].
Genes not included in both datasets were excluded from the
analysis. Myc binding promoter –associated genes were annotated
using Panther software (http://www.pantherdb.org/) [82]. Genes
that are not assigned to a biological process (biological process
unclassified) were not included in the figures. Each list is compared
to the reference list (NCBI:M. Musculus genes) using the binomial
test for each biological process term.
Manipulating c-Myc Level in ES Cells by Lentiviral-
Delivered Overexpression or shRNA Knock-Down
c-Myc cDNA was amplified from ES-derived cDNA library and
cloned into lentiviral vector pLenti6/V5-DEST (Invitrogen) for
overexpression. The shRNA sequences against c-Myc was
designed by using Dharmacon siDESIGN and then hairpin
shRNA oligonucleotides were annealed and cloned into modified
FUGW lenti-vector with H1 promoter (modified by Dr. Valera
Vasioukhin). Lentiviral production was followed the protocol
described in Lois C. et. al., Science, 2002, then drug selection for
positive integration in ES cells followed by 3 days infection.
Positive clones were picked and expanded for custom ChIP-chip
array, qChIP-PCR, gene expression analysis by RT-PCR, and
differentiation subsequent to LIF withdraw.
Gene Expression Analysis by RT-PCR
Total RNA was extracted by TRIzol (Invitrogen) reagent and
cDNA was synthesized by SuperScript II kit (Invitrogen) according
to the manufacturer’s instructions. The transcript expression level
was measured by Real-Time PCR with SYBR Green detection on
ABI7900HT system (Applied Biosystems). S16 RNA was used as
internal control for normalization (DCt). The expression level was
measured by subtraction of DCt from either overexpression or
knock-down to vector control (DDCt). Primers for Real-Time PCR
are available upon request.
Proliferation and Growth Rate Assay FACS Analysis
MTT assays: ES cells were seeded 1000 cells per well of 0.1%
gelatin-coated 96-well plate supplied with LIF and analyzed 24,
48, 72, 96 hours after plating. At each time point, ES cell medium
was replaced with 100 ml 1 mg/ml MTT (Molecular Probe) for
labeling. Subsequently, 100 ml of SDS-HCl was added to each well
and mixed thoroughly after 3 hours labeling at 37uC. Following 4
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was recorded at 570 nm. Triplicate analysis was applied to each
time point.
Population doubling time assay: 10
5 cells was plated on 1 well of
6-well plate and counted by SSEA-1 positive population after 24
and 48 hours later. Briefly, ES cells were harvested by trypsin and
washed with PBS prior to SSEA-1 (mouse monoclonal 1:200
dilution) antibody incubation for 2 hours. After washing with PBS
twice, cells were incubated with FITC-conjugated secondary
antibody for 1 hour. Finally, cells were washed twice and
resuspended in PBS before FACS analysis. The population (%)
of positive SSEA-1 stained cells was compared to unstained cells,
FITC-isotype control, undifferentiated ES cells, and cells stained
with secondary antibody alone. The SSEA-1 positive cell numbers
were subjected to the calculation of ’’cell population doubling
time‘‘ with the equation Yend=Y start62
(t/T).
Supporting Information
Figure S1 Identification of Myc binding sites in ES cells. In
addition to the log2 ratio .2 we also applied the widely used
ACME/R anaylsis which employs a sliding window=500 b.p. and
a threshold=95% across gene promoters to determine significance
(p-value) of each probe. Our identification of Myc binding sites is
based on significant peaks (ACME: p-value ,0.0001) that take
into account binding events on neighboring probes. Shown are a
few typical promoters in which are plotted log2 (NimbleGen
enrichment ratio scale on left ; probes =green dots) and -log10
(ACME p value in red. Scale is shown on right of each figure).
Found at: doi:10.1371/journal.pone.0007839.s001 (0.15 MB
PDF)
Figure S2 Validation of anti-Myc ChIP-chip results in the R1
mES cell line We randomly selected 44 genes for validation and
confirmed the enrichment of 44 genes on the array by qChIP-
PCR. Known Myc target genes such as Bmi1 served as a positive
control. Genes Evx2 and Sox21 not identified in our ChIP-chip
analysis and not previously reported as c-Myc targets were used as
negative controls for validation by qChIP-PCR. Bar heights
represent the mean ‘‘Fold’’ enrichment from 2 independent sets of
anti-Myc ChIP-enriched versus total input genomic DNA. Six
genes were not consistent in both our ChIP-chip assay and qChIP-
PCR. From this we calculate the average ‘‘false discovery rate’’ in
R1 ES cells to be 11.3%.
Found at: doi:10.1371/journal.pone.0007839.s002 (0.01 MB
PDF)
Figure S3 Determination of ES cells proliferation rate in
response to c-Myc level. c-Myc levels were manipulated by
Lentiviral-delivered overexpression or shRNA knock-down of c-
Myc in ES cells. (A) BrdU labeling of a representative ES colonies.
(B) Mean growth rate was measured by MTT assay. Mean was
measured from triplicate experiments. (C) Mean population
doubling time obtained from 4 independent experiments.
Found at: doi:10.1371/journal.pone.0007839.s003 (0.03 MB
PDF)
Figure S4 Sox2 and HirA protein expression in mES cells.
Antibodies against Sox2 and HirA were used for immunoblots
prepared from mES cells infected with empty lentiviral vector
alone (WT; left panel); with a lentiviral vector expression shRNA
against c-myc (middle panel); or with a lentiviral vector expressing
c-myc (right panel). c-tubulin was used for loading control.
Found at: doi:10.1371/journal.pone.0007839.s004 (0.04 MB
PDF)
Figure S5 H3-K27me3 (red) and H3-K4me3 (green) patterns at
promoters of genes activated following c-Myc overexpression.
DNA immunprecipitated with anti-H3-K4me3 or anti-H3-
K27me3 was applied to the custom-designed array (see text).
Enrichment ratios (log2 scale) for ChIP-enriched versus total input
genomic DNA for 427 genes were processed by ACME and
assigned p-values (-log10; y axis) identifying significant sites were
plotted (see Methods). Red peaks present H3-K27me3 and green
peaks present H3-K4me3.
Found at: doi:10.1371/journal.pone.0007839.s005 (1.49 MB
PDF)
Figure S6 H3-K27me3 (red) and H3-K4me3 (green) patterns at
promoters of genes repressed following c-Myc overexpression.
DNA immunprecipitated with anti-H3-K4me3 or anti-H3-
K27me3 was applied to the custom-designed array (see text).
Enrichment ratios (log2 scale) for ChIP-enriched versus total input
genomic DNA for 427 genes were processed by ACME and
assigned p-values (-log10; y axis) identifying significant sites were
plotted (see Methods). Red peaks present H3-K27me3 and green
peaks present H3-K4me3.
Found at: doi:10.1371/journal.pone.0007839.s006 (1.14 MB
PDF)
Figure S7 H3-K27me3 (red) and H3-K4me3 (green) patterns at
promoters in which bivalency is partly lost upon c-Myc
overexpression. DNA immunprecipitated with anti-H3-K4me3
or anti-H3-K27me3 was applied to the custom-designed array (see
text). Enrichment ratios (log2 scale) for ChIP-enriched versus total
input genomic DNA for 427 genes were processed by ACME and
assigned p-values (-log10; y axis) identifying significant sites were
plotted (see Methods). Red peaks present H3-K27me3 and green
peaks present H3-K4me3.
Found at: doi:10.1371/journal.pone.0007839.s007 (4.21 MB
PDF)
Figure S8 H3-K27me3 (red) and H3-K4me3 (green) patterns at
promoters in which bivalency is gained upon c-Myc overexpres-
sion. DNA immunprecipitated with anti-H3-K4me3 or anti-H3-
K27me3 was applied to the custom-designed array (see text).
Enrichment ratios (log2 scale) for ChIP-enriched versus total input
genomic DNA for 427 genes were processed by ACME and
assigned p-values (2log10; y axis) identifying significant sites were
plotted (see Methods). Red peaks present H3-K27me3 and green
peaks present H3-K4me3.
Found at: doi:10.1371/journal.pone.0007839.s008 (1.11 MB
PDF)
Figure S9 H3-K27me3 (red) and H3-K4me3 (green) patterns at
promoters showing only small or no changes in H3-K27me3 and
H3-K4me 3 pattern. DNA immunprecipitated with anti-H3-
K4me3 or anti-H3-K27me3 was applied to the custom-designed
array (see text). Enrichment ratios (log2 scale) for ChIP-enriched
versus total input genomic DNA for 427 genes were processed by
ACME and assigned p-values (2log10; y axis) identifying
significant sites were plotted (see Methods). Red peaks present
H3-K27me3 and green peaks present H3-K4me3.
Found at: doi:10.1371/journal.pone.0007839.s009 (5.05 MB
PDF)
Figure S10 c-Myc binding sites on a subset of gene promoters in
mES cells. c-Myc levels were manipulated by Lentiviral-delivered
overexpression or knock-down of c-Myc in mES cells followed by
anti-Myc ChIP-chip analysis on custom- designed arrays (see text).
Unprocessed enrichment ratios (log2 scale) present ChIP-enriched
versus total input genomic DNA (crosslinked, sonicated and
processed identically to the ChIP sample) (y axis) for all probes
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TSS. The TSS and direction of transcription are denoted by
arrows at the bottom of the figure. Blue bars: endogenous c-Myc
binding in WT mES cells, Red bars: Myc overexpressing mES
cells, Green bars: Myc knock-down mES cells. Negative values
occur when there is no enrichment in ChIP DNA relative to input.
Found at: doi:10.1371/journal.pone.0007839.s010 (0.16 MB
PDF)
Table S1 List of Myc associated promoters in AK7 ES cells.
Found at: doi:10.1371/journal.pone.0007839.s011 (0.58 MB
XLS)
Table S2 Myc associated promoters showing H3-K27me3 Myc
associated promoters showing Suz12 binding Myc associated
promoters showing Suz12 binding and H3-K27me3 Note: data on
Suz12 and H3-K27me3 from Boyer et al. 2006 (ref 16).
Found at: doi:10.1371/journal.pone.0007839.s012 (0.15 MB
XLS)
Table S3 List of genes organized into groups according to
whether they are activated or repressed by c-Myc overexpression;
whether they lose or gain bivalent H3-methylation marks; or show
little or no change in methylation pattern. The individual pattern
for each gene on the list is presented in Figs. S5–S9.
Found at: doi:10.1371/journal.pone.0007839.s013 (0.02 MB
XLS)
Table S4 List of genes included in custom-design microarray
Found at: doi:10.1371/journal.pone.0007839.s014 (0.50 MB
XLS)
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